Bradykinin promotes migration and invasion of human immortalized trophoblasts

Reproductive Biology and Endocrinology

Volumn 9, Issue , 2011, Pages

  Erices, Rafaela ^a   Corthorn, Jenny ^a   Lisboa, Francisco ^a   Valdés, Gloria ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; CELL PROTEIN; GELATINASE A; GELATINASE B; HLA ANTIGEN; HLA G ANTIGEN; KALLIKREIN; KININOGEN; DRUG DERIVATIVE; ICATIBANT;

ARTICLE; CELL CULTURE; CELL CYCLE; CELL IMMORTALIZATION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; PROTEIN EXPRESSION; TROPHOBLAST; WESTERN BLOTTING; WOUND HEALING; ZYMOGRAPHY; BIOSYNTHESIS; CELL LINE; CELL MOTION; DRUG ANTAGONISM; DRUG EFFECT; PHYSIOLOGY; PSEUDOPODIUM;

CAVIA;

BRADYKININ; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PSEUDOPODIA; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2; TROPHOBLASTS; WOUND HEALING;

EID: 79959858445     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-9-97     Document Type: Article

References (66)

1. Kaufmann P, Black S, Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 2003, 69:1-7. 10.1095/biolreprod.102.014977, 12620937.
2. Red-Horse K, Zhou Y, Genbacev O, Prakobphol A, Foulk R, McMaster M, Fisher SJ. Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface. J Clin Invest 2004, 114:744-754. 516273, 15372095.
3. Lunghi L, Ferretti ME, Medici S, Biondi C, Vesce F. Control of human trophoblast function. Reprod Biol Endocrinol 2007, 5:6. 10.1186/1477-7827-5-6, 1800852, 17288592.
4. Silasi M, Cohen B, Karumanchi SA, Rana S. Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia. Obstet Gynecol Clin North Am 37:239-253.
5. Roberts JM, Hubel CA. The two stage model of preeclampsia: variations on the theme. Placenta 2009, 30(Suppl A):S32-37. 2680383, 19070896.
6. Norwitz ER. Defective implantation and placentation: laying the blueprint for pregnancy complications. Reprod Biomed Online 2006, 13:591-599. 10.1016/S1472-6483(10)60649-9, 17007686.
7. Goldman-Wohl D, Yagel S. Regulation of trophoblast invasion: from normal implantation to pre-eclampsia. Mol Cell Endocrinol 2002, 187:233-238. 10.1016/S0303-7207(01)00687-6, 11988332.
8. Zhou Y, Genbacev O, Fisher SJ. The human placenta remodels the uterus by using a combination of molecules that govern vasculogenesis or leukocyte extravasation. Ann N Y Acad Sci 2003, 995:73-83. 10.1111/j.1749-6632.2003.tb03211.x, 12814940.
9. Staun-Ram E, Goldman S, Gabarin D, Shalev E. Expression and importance of matrix metalloproteinase 2 and 9 (MMP-2 and -9) in human trophoblast invasion. Reprod Biol Endocrinol 2004, 2:59. 10.1186/1477-7827-2-59, 516041, 15294019.
10. Lala PK, Nicola C, Chakraborty C. Effects of PGE2 on human trophoblast proliferation and migration. Placenta 2010, 27:928-929.
11. Demir-Weusten AY, Seval Y, Kaufmann P, Demir R, Yucel G, Huppertz B. Matrix metalloproteinases-2, -3 and -9 in human term placenta. Acta Histochem 2007, 109:403-412. 10.1016/j.acthis.2007.04.001, 17559909.
12. Damsky CH, Librach C, Lim KH, Fitzgerald ML, McMaster MT, Janatpour M, Zhou Y, Logan SK, Fisher SJ. Integrin switching regulates normal trophoblast invasion. Development 1994, 120:3657-3666.
13. Sargent IL, Borzychowski AM, Redman CW. Immunoregulation in normal pregnancy and pre-eclampsia: an overview. Reprod Biomed Online 2006, 13:680-686. 10.1016/S1472-6483(10)60659-1, 17169180.
14. Nanaev A, Chwalisz K, Frank HG, Kohnen G, Hegele-Hartung C, Kaufmann P. Physiological dilation of uteroplacental arteries in the guinea pig depends on nitric oxide synthase activity of extravillous trophoblast. Cell Tissue Res 1995, 282:407-421. 10.1007/BF00318873, 8581935.
15. Valdés G, Kaufmann P, Corthorn J, Erices R, Brosnihan KB, Joyner-Grantham J. Vasodilator factors in the systemic and local adaptations to pregnancy. Reprod Biol Endocrinol 2009, 7:79. 10.1186/1477-7827-7-79, 2739214, 19646248.
16. Corthorn J, Germain AA, Chacón C, Rey S, Soto GX, Figueroa CD, Muller-Esterl W, Duarte I, Valdés G. Expression of kallikrein, bradykinin B2 receptor, and endothelial nitric oxide synthase in placenta in normal gestation, preeclampsia, and placenta accreta. Endocrine 2006, 29:491-499. 10.1385/ENDO:29:3:491, 16943589.
17. Calixto JB, Medeiros R, Fernandes ES, Ferreira J, Cabrini DA, Campos MM. Kinin B1 receptors: key G-protein-coupled receptors and their role in inflammatory and painful processes. Br J Pharmacol 2004, 143:803-818. 10.1038/sj.bjp.0706012, 1575942, 15520046.
18. Moreau ME, Garbacki N, Molinaro G, Brown NJ, Marceau F, Adam A. The kallikrein-kinin system: current and future pharmacological targets. J Pharmacol Sci 2005, 99:6-38. 10.1254/jphs.SRJ05001X, 16177542.
19. Valdés G, Germain AM, Corthorn J, Chacon C, Figueroa CD, Muller-Esterl W. Tissue kallikrein and bradykinin B2 receptor in human uterus in luteal phase and in early and late gestation. Endocrine 2001, 16:207-215. 10.1385/ENDO:16:3:207, 11954665.
20. Valdés G, Chacón C, Corthorn J, Figueroa CD, Germain AM. Tissue kallikrein in human placenta in early and late gestation. Endocrine 2001, 14:197-204. 10.1385/ENDO:14:2:197, 11394637.
21. Figueroa CD, Chacón C, Corthorn J, Ehrenfeld P, Müller-Esterl W, Valdés G. Temporospatial changes of kinin B2 receptors during the estrous cycle and pregnancy in the rat uterus. Biol Reprod 2001, 64:1590-1599. 10.1095/biolreprod64.6.1590, 11369583.
22. Buchinger P, Rehbock J. The bradykinin B2-receptor in human decidua. Semin Thromb Hemost 1999, 25:543-549. 10.1055/s-2007-994963, 10632476.
23. Valdés G, Erices R, Chacón C, Corthorn J. Angiogenic, hyperpermeability and vasodilator network in utero-placental units along pregnancy in the guinea-pig (Cavia porcellus). Reprod Biol Endocrinol 2008, 6:13. 10.1186/1477-7827-6-13, 2291058, 18371207.
24. Lauffenburger DA, Horwitz AF. Cell migration: a physically integrated molecular process. Cell 1996, 84:359-369. 10.1016/S0092-8674(00)81280-5, 8608589.
25. Mitchison TJ, Cramer LP. Actin-based cell motility and cell locomotion. Cell 1996, 84:371-379. 10.1016/S0092-8674(00)81281-7, 8608590.
26. Pollard TD, Borisy GG. Cellular motility driven by assembly and disassembly of actin filaments. Cell 2003, 112:453-465. 10.1016/S0092-8674(03)00120-X, 12600310.
27. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT, Horwitz AR. Cell migration: integrating signals from front to back. Science 2003, 302:1704-1709. 10.1126/science.1092053, 14657486.
28. Liesmaa I, Leskinen HK, Kokkonen JO, Ruskoaho H, Kovanen PT, Lindstedt KA. Hypoxia-induced expression of bradykinin type-2 receptors in endothelial cells triggers NO production, cell migration, and angiogenesis. J Cell Physiol 2009, 221:359-366. 10.1002/jcp.21861, 19565561.
29. Krankel N, Katare RG, Siragusa M, Barcelos LS, Campagnolo P, Mangialardi G, Fortunato O, Spinetti G, Tran N, Zacharowski K, et al. Role of kinin B2 receptor signaling in the recruitment of circulating progenitor cells with neovascularization potential. Circ Res 2008, 103:1335-1343. 10.1161/CIRCRESAHA.108.179952, 2821015, 18927465.
30. Ehrenfeld P, Millan C, Matus CE, Figueroa JE, Burgos RA, Nualart F, Bhoola KD, Figueroa CD. Activation of kinin B1 receptors induces chemotaxis of human neutrophils. J Leukoc Biol 2006, 80:117-124. 10.1189/jlb.1205744, 16670123.
31. Paegelow I, Trzeczak S, Bockmann S, Vietinghoff G. Migratory responses of polymorphonuclear leukocytes to kinin peptides. Pharmacology 2002, 66:153-161. 10.1159/000063797, 12372905.
32. McFadden RG, Vickers KE. Bradykinin augments the in vitro migration of nonsensitized lymphocytes. Clin Invest Med 1989, 12:247-253.
33. Kozma R, Ahmed S, Best A, Lim L. The Ras-related protein Cdc42Hs and bradykinin promote formation of peripheral actin microspikes and filopodia in Swiss 3T3 fibroblasts. Mol Cell Biol 1995, 15:1942-1952. 230420, 7891688.
34. Bertram CM, Baltic S, Misso NL, Bhoola KD, Foster PS, Thompson PJ, Fogel-Petrovic M. Expression of kinin B1 and B2 receptors in immature, monocyte-derived dendritic cells and bradykinin-mediated increase in intracellular Ca2+ and cell migration. J Leukoc Biol 2007, 81:1445-1454. 10.1189/jlb.0106055, 17327486.
35. Ifuku M, Farber K, Okuno Y, Yamakawa Y, Miyamoto T, Nolte C, Merrino VF, Kita S, Iwamoto T, Komuro I, et al. Bradykinin-induced microglial migration mediated by B1-bradykinin receptors depends on Ca2+ influx via reverse-mode activity of the Na+/Ca2+ exchanger. J Neurosci 2007, 27:13065-13073. 10.1523/JNEUROSCI.3467-07.2007, 18045900.
36. Yang WH, Chang JT, Hsu SF, Li TM, Cho DY, Huang CY, Fong YC, Tang CH. Bradykinin enhances cell migration in human chondrosarcoma cells through BK receptor signaling pathways. J Cell Biochem 2010, 109:82-92.
37. Ehrenfeld P, Conejeros I, Pavicic MF, Matus CE, González CB, Quest AF, Bhoola KD, Poblete MT, Burgos RA, Figueroa CD. Activation of kinin B1 receptor increases the release of metalloproteases-2 and -9 from both estrogen-sensitive and-insensitive breast cancer cells. Cancer Lett 2011, 301:106-118. 10.1016/j.canlet.2010.09.020, 21147512.
38. Baba K, Yamaguchi O. Effects of bradykinin on cytoplasmic calcium and motility in murine bladder tumor cells. J Urol 2001, 165:259-262. 10.1097/00005392-200101000-00075, 11125421.
39. Hsieh HL, Wu CY, Yang CM. Bradykinin induces matrix metalloproteinase-9 expression and cell migration through a PKC-delta-dependent ERK/Elk-1 pathway in astrocytes. Glia 2008, 56:619-632. 10.1002/glia.20637, 18240315.
40. Graham CH. Effect of transforming growth factor-beta on the plasminogen activator system in cultured first trimester human cytotrophoblasts. Placenta 1997, 18:137-143. 10.1016/S0143-4004(97)90085-0, 9089774.
41. Graham CH, Fitzpatrick TE, McCrae KR. Hypoxia stimulates urokinase receptor expression through a heme protein-dependent pathway. Blood 1998, 91:3300-3307.
42. Graham CH, Hawley TS, Hawley RG, MacDougall JR, Kerbel RS, Khoo N, Lala PK. Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Exp Cell Res 1993, 206:204-211. 10.1006/excr.1993.1139, 7684692.
43. Lash GE, Hornbuckle J, Brunt A, Kirkley M, Searle RF, Robson SC, Bulmer JN. Effect of low oxygen concentrations on trophoblast-like cell line invasion. Placenta 2007, 28:390-398. 10.1016/j.placenta.2006.06.001, 16905187.
44. Kilburn BA, Wang J, Duniec-Dmuchowski ZM, Leach RE, Romero R, Armant DR. Extracellular matrix composition and hypoxia regulate the expression of HLA-G and integrins in a human trophoblast cell line. Biol Reprod 2000, 62:739-747. 10.1095/biolreprod62.3.739, 10684818.
45. Corthorn J, Valdés G. Variations in uterine kallikrein during cycle and early pregnancy in the rat. Biol Reprod 1994, 50:1261-1264. 10.1095/biolreprod50.6.1261, 8080914.
46. Corthorn J, Rey S, Chacon C, Valdés G. Spatio-temporal expression of MMP-2, MMP-9 and tissue kallikrein in uteroplacental units of the pregnant guinea-pig (Cavia porcellus). Reprod Biol Endocrinol 2007, 5:27. 10.1186/1477-7827-5-27, 1934362, 17605824.
47. Bilban M, Tauber S, Haslinger P, Pollheimer J, Saleh L, Pehamberger H, Wagner O, Knofler M. Trophoblast invasion: assessment of cellular models using gene expression signatures. Placenta 2010, 31:989-996. 10.1016/j.placenta.2010.08.011, 20850871.
48. Nobes CD, Hall A. Rho GTPases control polarity, protrusion, and adhesion during cell movement. J Cell Biol 1999, 144:1235-1244. 10.1083/jcb.144.6.1235, 2150589, 10087266.
49. Brakebusch C, Fassler R. The integrin-actin connection, an eternal love affair. Embo J 2003, 22:2324-2333. 10.1093/emboj/cdg245, 156003, 12743027.
50. Petrovic N, Schacke W, Gahagan JR, O'Conor CA, Winnicka B, Conway RE, Mina-Osorio P, Shapiro LH. CD13/APN regulates endothelial invasion and filopodia formation. Blood 2007, 110:142-150. 10.1182/blood-2006-02-002931, 1896108, 17363739.
51. Nicola C, Lala PK, Chakraborty C. Prostaglandin E2-mediated migration of human trophoblast requires RAC1 and CDC42. Biol Reprod 2008, 78:976-982. 10.1095/biolreprod.107.065433, 18235104.
52. Horita H, Kuroda E, Hachisuga T, Kashimura M, Yamashita U. Induction of prostaglandin E2 production by leukemia inhibitory factor promotes migration of first trimester extravillous trophoblast cell line, HTR-8/SVneo. Hum Reprod 2007, 22:1801-1809. 10.1093/humrep/dem125, 17525067.
53. Zhang W, Bhola N, Kalyankrishna S, Gooding W, Hunt J, Seethala R, Grandis JR, Siegfried JM. Kinin B2 receptor mediates induction of cyclooxygenase-2 and is overexpressed in head and neck squamous cell carcinomas. Mol Cancer Res 2008, 6:1946-1956. 10.1158/1541-7786.MCR-07-2197, 19074839.
54. Bradbury DA, Newton R, Zhu YM, El-Haroun H, Corbett L, Knox AJ. Cyclooxygenase-2 induction by bradykinin in human pulmonary artery smooth muscle cells is mediated by the cyclic AMP response element through a novel autocrine loop involving endogenous prostaglandin E2, E-prostanoid 2 (EP2), and EP4 receptors. J Biol Chem 2003, 278:49954-49964. 10.1074/jbc.M307964200, 14517215.
55. Brown NJ, Gainer JV, Murphey LJ, Vaughan DE. Bradykinin stimulates tissue plasminogen activator release from human forearm vasculature through B(2) receptor-dependent, NO synthase-independent, and cyclooxygenase-independent pathway. Circulation 2000, 102:2190-2196.
56. Huber AV, Saleh L, Bauer S, Husslein P, Knofler M. TNFalpha-mediated induction of PAI-1 restricts invasion of HTR-8/SVneo trophoblast cells. Placenta 2006, 27:127-136.
57. Chou CS, Zhu H, Shalev E, MacCalman CD, Leung PC. The effects of gonadotropin-releasing hormone (GnRH) I and GnRH II on the urokinase-type plasminogen activator/plasminogen activator inhibitor system in human extravillous cytotrophoblasts in vitro. J Clin Endocrinol Metab 2002, 87:5594-5603. 10.1210/jc.2002-020883, 12466358.
58. Valdés G, Corthorn J, Oyarzún E, Berríos C, Foradori A, Germain AM, L V. Urinary kallikrein excretion in the human menstrual cycle, normal pregnancy and lactation. Prenat Neonat Med 1998, 3:474-481.
59. Elebute OA, Mills IH. Urinary kallikrein in normal and hypertensive pregnancies. Perspect Nephrol Hypertens 1976, 5:329-338.
60. Millar JG, Campbell SK, Albano JD, Higgins BR, Clark AD. Early prediction of pre-eclampsia by measurement of kallikrein and creatinine on a random urine sample. Br J Obstet Gynaecol 1996, 103:421-426. 10.1111/j.1471-0528.1996.tb09767.x, 8624314.
61. Valdés G, Figueroa CD, Corthorn J. Temporospatial changes of kallikrein-like enzymes during the estrous cycle and pregnancy in the rat uterus. Biol Reprod 1996, 55:236-245. 10.1095/biolreprod55.2.236, 8828825.
62. Valdés G, Corthorn J, Scicli AG, Gaete V, Soto J, Ortíz ME, Foradori A, Saed GM. Uterine kallikrein in the early pregnant rat. Biol Reprod 1993, 49:802-808. 10.1095/biolreprod49.4.802, 8218645.
63. Quitterer U, Lother H, Abdalla S. AT1 receptor heterodimers and angiotensin II responsiveness in preeclampsia. Semin Nephrol 2004, 24:115-119. 10.1016/j.semnephrol.2003.11.007, 15017523.
64. AbdAlla S, Lother H, el Massiery A, Quitterer U. Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat Med 2001, 7:1003-1009. 10.1038/nm0901-1003, 11533702.
65. Seeho SK, Park JH, Rowe J, Morris JM, Gallery ED. Villous explant culture using early gestation tissue from ongoing pregnancies with known normal outcomes: the effect of oxygen on trophoblast outgrowth and migration. Hum Reprod 2008, 23:1170-1179. 10.1093/humrep/den066, 18325889.
66. Campbell S, Rowe J, Jackson CJ, Gallery ED. Interaction of cocultured decidual endothelial cells and cytotrophoblasts in preeclampsia. Biol Reprod 2004, 71:244-252. 10.1095/biolreprod.103.026716, 15028631.